Abstract:ObjectivesPulmonary arterial hypertension (PAH) is a severe complication of connective tissue disease (CTD) with a poor prognosis. There have been sporadic reports with respect to the clinical features and survival of CTD associated PAH (CPAH), however, those in Chinese with CPAH are unknown yet. The purpose of this study is to investigate the baseline characteristics, survival and risk factors of mortality in Chinese with CPAH.MethodsAll consecutive adult patients who visited the three medical centres with confirmed diagnosis of CPAH between July 2006 and May 2011 were enrolled into the study. For all these patients, PAH was confirmed by right heart catheterisation.ResultsA total of 144 patients (40.6±12.6 years old) were included in the study and 44% of them were associated with SLE. The other underlying CTDs, in the descending rank order, are pSS (15%), Takayasu arteritis (12%), MCTD (10%), SSc (8%) and some others (RA 3%, PM/DM 2%, adult onset Still9disease 2%, UCTD 2%, primary APS 1%, and ANCA associated vasculitis 1%). The median duration between symptom onset and diagnostic catheterisation was 16.5 months. At diagnosis, 57.6% of patients were in WHO functional class III/IV. The 6-min walk distance was 377.0±99.7 m. Mean pulmonary artery pressure was 49.7±14.4 mm Hg. Eighty-five percent of patients received vascular-targeted therapy. One hundred and twenty-nine patients were followed up with a median duration of 15.8 months (ranged 1.1–55.1 months). The survival rates of these patients at 1 and 3 years were 87.8% and 53.8%. The survival rates of patients with SLE associated PAH at 1 and 3 years were 90.0% and 57.1%. K-M survival analysis showed there were no significant differences in the survivals among different connective tissue diseases. Univariate Cox analysis showed shorter 6-min walk distance, lower cardiac output, cardiac index and mixed venous oxygen saturation, higher pulmonary vascular resistance (PVR), alkaline phosphatase (ALP), total bilirubin and direct bilirubin, lower total cholesterol and low-density lipoprotein were associated with high risk of death (all p<0.05). Multivariate Cox analysis showed higher PVR and ALP were independent predictors of mortality (HR were 1.32 (1.03–1.68) and 1.70 (1.01–2.87) respectively, both p<0.05). K-M analysis demonstrated the survival rate in PVR<15 wood unit group was higher significantly than that in ≥15 wood unit group (p=0.009), and the survival rate in ALp<150 U/l group higher than that in ≥150 U/l group (p=0.012).ConclusionsSLE was the most common underlying disease of CPAH in China; however, SSc-associated PAH was fewer in Chinese patients, which were much different from Caucasians. The survival of Chinese patients with CPAH at 1 and 3 years were 87.8% and 53.8%, which were similar with the data of Western countries. Furthermore, elevated PVR and ALP were independent risk factors of bad outcomes.

Elevated Levels of Circulating BMP7 Predict Mortality in Pulmonary Arterial Hypertension

Elevated Levels of Circulating Bone Morphogenetic Protein 7 Predict Mortality in Pulmonary Arterial Hypertension.

The effection of idiopathic pulmonary hypertension on endothelial progenitor cells and bone morphogenetic protein-2

Circulating Bone Morphogenetic Protein-9 Levels Are Associated with Hypertension and Insulin Resistance in Humans

BMP10 reflects pre-capillary pulmonary hemodynamics: association of biomarkers and hemodynamic parameters in pulmonary hypertension

Abstract 15826: SCUBE1 Controls BMPR2-relevant Pulmonary Endothelial Function: Implications for Diagnostic Marker Development in Pulmonary Arterial Hypertension

HMGB2 Release Promotes Pulmonary Hypertension and Predicts Severity and Mortality of Patients With Pulmonary Arterial Hypertension

Prognostic Significance of Proteomics-Discovered Circulating Inflammatory Biomarkers in Patients With Pulmonary Arterial Hypertension

The Associations of Blood Pressure Parameters with All-Cause and Cardiovascular Mortality in Peritoneal Dialysis Patients: a Cohort Study in China.

High Alkaline Phosphatase and Low Intact Parathyroid Hormone Associate with Worse Clinical Outcome in Peritoneal Dialysis Patients

Bone morphogenetic protein signalling in pulmonary arterial hypertension: revisiting the BMPRII connection

BMP9 attenuates IL-33 signaling and prevents endothelial-to-mesenchymal transition in pulmonary arterial hypertension

Increased bone morphogenetic protein 10 in precapillary pulmonary hypertension patients

Abstract 18578: BMP9 Regulates Endothelial Expression of Mediators of Pulmonary Vascular Remodeling

Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study

Prognostic Value of Novel Hematologic Biomarkers in Patients with Pulmonary Arterial Hypertension

Elevated circulating BMP9 aggravates pulmonary angiogenesis in hepatopulmonary syndrome rats through ALK1‐Endoglin‐Smad1/5/9 signalling

Evaluating the role of serum uric acid in the risk stratification and therapeutic response of patients with pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD)

P158 Pulmonary Vascular Disease Markers Predict Death in Interstitial Lung Disease Patients Proven Not to Have Pulmonary Hypertension at Right Heart Catheter

Baseline Characteristics And Survival Of Chinese Patients With Connective Tissue Disease-Associated Pulmonary Arterial Hypertension

Assessing causal associations of blood counts and biochemical indicators with pulmonary arterial hypertension: a Mendelian randomization study and results from national health and nutrition examination survey 2003–2018